Orfadin Interactions
There are 243 drugs known to interact with Orfadin (nitisinone), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 9 are major, 230 are moderate, and 4 are minor.
- View all 243 medications that may interact with Orfadin
- View Orfadin alcohol/food interactions (1)
- View Orfadin disease interactions (1)
Most frequently checked interactions
View interaction reports for Orfadin (nitisinone) and the medicines listed below.
- Actemra (tocilizumab)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Corlanor (ivabradine)
- Crixivan (indinavir)
- Enbrel (etanercept)
- Esbriet (pirfenidone)
- Fasenra (benralizumab)
- Feiba (anti-inhibitor coagulant complex)
- Hemlibra (emicizumab)
- Isentress (raltegravir)
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Matulane (procarbazine)
- Norvir (ritonavir)
- NovoSeven RT (coagulation factor viia)
- Ofev (nintedanib)
- Onpattro (patisiran)
- Prograf (tacrolimus)
- Pulmozyme (dornase alfa)
- Repatha (evolocumab)
- Rescriptor (delavirdine)
- Sensipar (cinacalcet)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Sucraid (sacrosidase)
- Tecentriq (atezolizumab)
- Tecfidera (dimethyl fumarate)
- Videx (didanosine)
- Viread (tenofovir disoproxil)
Orfadin alcohol/food interactions
There is 1 alcohol/food interaction with Orfadin (nitisinone).
Orfadin disease interactions
There is 1 disease interaction with Orfadin (nitisinone) which include:
Report options
More about Orfadin (nitisinone)
- Orfadin consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: miscellaneous metabolic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Aqneursa
Aqneursa information from Drugs.com, includes Aqneursa side effects, interactions and indications.
Cerdelga
Cerdelga (eliglustat) is used to treat mild to moderate Type 1 Gaucher Disease. Includes Cerdelga ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Crysvita
Crysvita is used for familial hypophosphatemia, osteomalacia, X-Linked Hypophosphatemia
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Givlaari
Givlaari injection is used for acute hepatic porphyria (AHP) to reduce the number of acute attacks ...
Iqirvo
Iqirvo (elafibranor) is used to treat primary biliary cholangitis (PBC) in combination with ...
Kuvan
Kuvan is used to help the body activate the enzyme needed to control blood levels of phenylalanine ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
